Advanced Fellowship in Thoracic Oncology

Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) Advanced Fellowship in  Thoracic Oncology: Request for Applications 

Introduction 
The Advanced Fellowship in Thoracic Oncology is designed to provide comprehensive clinical and investigative training in the care and management of patients with lung cancer for individuals planning a  career in applied oncology research in an academic setting. This Advanced Fellowship offers outstanding  junior oncologists exposure to state-of-the-art lung cancer care, clinical trials, and translational research  within the Dana-Farber/Brigham and Women’s Cancer Center and Harvard Medical School network. On  completion of this 2-year fellowship, Advanced Fellows will receive a certificate from DF/BWCC and  will have developed relationships with an international network of lung cancer research collaborators. 

Eligibility 

Candidates for the Advanced Fellowship in Thoracic Oncology must have: 

• Completed training in Medical Oncology (minimum 2 years) or Hematology/Oncology  (minimum 3 years) and be eligible for a limited or permanent medical license from the  Commonwealth of Massachusetts. A limited US medical license is preferred for this fellowship;  however, the department can help the Advanced Fellow obtain a limited license. 

• Developed an interest in lung cancer during oncology training. 

• Physicians applying for an initial full license will be required to pass USMLE Step 1, 2 and 3;  FLEX Components 1 and 2; NMBE parts I, II, and III; or all parts of MCCQE. Applicants to this  fellowship must have completed or be in the process of undertaking Licensing Examinations. 

• A full license is not required for this fellowship, however in order to be eligible for a full license,  international medical graduates must complete three (3) years of postgraduate training in an  ACGME accredited or AOA approved or accredited Canadian program. In the case of a  subspecialty clinical fellowship program such as this Advanced Fellowship, post-graduate  training in a hospital that has an ACGME accredited, or AOA approved or accredited Canadian  program in the parent specialty may be acceptable. 

Preference will be given to candidates with 

• Experience in clinical and/or laboratory research. 

• Partial funding from scholarships. 

• Proficiency in English. 

Job Description 

The Advanced Fellowship will have both research and clinical components. 

• Research (80%) 
  • The Advanced Fellow, in conjunction with a research mentor, will select a longitudinal  research project. Possible projects include clinical trial development and oversight,  analysis of large clinical databases, or pursuing a translational project in a research  laboratory. 
  • It is expected after 2 years of work: 
    • Original research data will be available for presentation at a local or national  conference 
    • The Fellow will attend weekly thoracic oncology research meetings and will  present research design and progress at least 1-2 times a year.
    • The Fellow will have authored 1-2 manuscripts (original research and/or review  article). 
    • The Fellow will have participated in grant submissions.
• Clinical (20%) 
  • The Advanced Fellow will spend 1 day a week in the ambulatory thoracic oncology clinic  seeing new and follow-up patients with attending faculty and building a continuity clinic  of patients to be followed throughout their treatment. The Fellow will also attend weekly  multi-disciplinary tumor board. 
• Educational opportunities for the Fellow may include 
  • Dana-Farber/Harvard Cancer Center Clinical Investigator’s Course (weekly 2-hour  seminar over 9 months, overseen by Harold Burstein, MD PhD). 
  • Harvard School of Public Health Clinical Effectiveness Course (6 weeks in Summer).
  • Methods in Clinical Cancer Research (MCCR) course offered through the American  Society of Clinical Oncology (ASCO) and American Association for Cancer Research  (AACR) 

Salary and fringe benefits 

• Year 1 Advanced Fellows will be paid as PGY6 and Advanced Fellows in Year 2 will be paid as  PGY7 
• Subsidized health insurance 
• 2 annual conferences per annum 
• 4 weeks annual leave 

Selection process and timelines 

• Fellowship will be advertised internationally 
• Rolling Application deadline 
  • Requirements 
    • Completion of application with following headings (do not exceed 3 pages) 
      • Training, prior clinical and research experiences 
      • Career interest and goals 
      • Reasons for pursuing fellowship 
      • Interests that applicant would want to pursue 
    • Curriculum Vitae. 
    • 3 letters of recommendation, to be attached with the above. 
• Within 3 months: Notification of selection 
• Advanced Fellowship start date upon acceptance is flexible but will generally be January 1 or  July 1 each year 
• Commencement of fellowship  

Please address application and queries to: 

Emily Silverman 
Administrative Director – Thoracic Oncology
450 Brookline Ave 
DA1233 
Boston, MA 02215 USA 
emily_zobacksilverman@dfci.harvard.edu